A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane ...

Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

Respiratory syncytial virus (RSV) causes symptoms similar to the common cold. But in older adults and those with certain medical conditions, the virus can increase the risk of serious illnesses. A ...

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged 75 years and above. Recent advancements in vaccine trials for older ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...